WhatsApp USA: +1 6032769350 | WhatsApp HK: +852 63697831
Global Healthcare Medical
GHM MxA US Myxovirus Resistance Protein A Test Kit (FIA) – Quantitative, 15-Minute, Whole Blood/Serum/Plasma
GHM MxA US Myxovirus Resistance Protein A Test Kit (FIA) – Quantitative, 15-Minute, Whole Blood/Serum/Plasma
SKU: GHM MxA US
Brand: Global Healthcare Medical
Product Overview
Global Healthcare Medical GHM MxA US Myxovirus Resistance Protein A Test Kit (FIA) is a fluorescence immunoassay (FIA) designed for the quantitative determination of Myxovirus Resistance Protein A (MxA) in human whole blood, serum, or plasma samples. The measurement of MxA is used as an aid in the diagnosis of acute respiratory viral infections in symptomatic patients.
MxA is an intracellular protein induced by type I interferon and becomes elevated during the early stages of viral infection, making it a reliable biomarker for viral immune response. In bacterial infections, MxA levels generally do not increase. The measurement of MxA supports the differentiation between viral and bacterial infections, which can assist clinicians in therapeutic decision-making and help reduce unnecessary antibiotic use.
The GHM MxA US is intended for use with the FIA Analyzer (VIM01), a compact benchtop analyzer that utilizes quantitative fluorescence immunochromatography technology. The test kit delivers results in 15 minutes with a measuring range of 10 ~ 300 ng/mL. The analyzer features auto calibration, barcode identification, and a built-in memory capacity of 50,000 results.
The system is designed for professional use in clinical laboratories, hospitals, and clinics. The FIA analyzer operates with a small sample volume and provides fast, reliable results with simple operation.
This product is for in vitro diagnostic use only. For professional use only.
Key Features & Benefits
Quantitative MxA Measurement – 15-Minute Turnaround
The GHM MxA US delivers quantitative MxA results in 15 minutes, supporting efficient clinical workflows in professional laboratory settings.
| Feature | Benefit |
|---|---|
| Test time | 15 minutes per test |
| Measuring range | 10 ~ 300 ng/mL |
| Specimen types | Whole blood, serum, plasma |
| Quantitative result | Provides measurable MxA concentration values |
| Intended use | Aid in diagnosis of acute respiratory viral infections in symptomatic patients |
| Analyzer test time | 10 ± 5 seconds for analyzer reading |
MxA as a Viral Infection Biomarker – Differentiating Viral from Bacterial Infections
MxA is an intracellular protein that increases in the presence of acute active viral infections. Its basal level is typically below 15 ng/mL, and elevated levels are detectable 1–2 hours after interferon induction and remain detectable in serum up to 10 days after viral infection. In bacterial infections, MxA levels generally do not increase, supporting the differentiation between viral and bacterial infections.
| Feature | Benefit |
|---|---|
| Early detection | MxA elevation is detectable within 1–2 hours of interferon induction |
| Extended detection window | Remains detectable in serum up to 10 days after viral infection |
| Viral specificity | MxA levels generally do not increase in bacterial infections |
| Clinical utility | Supports differentiation between viral and bacterial infections |
| Antibiotic stewardship | Helps reduce unnecessary antibiotic use |
Sandwich Immunodetection Method – Fluorescence Immunoassay Principle
The GHM MxA US uses a sandwich immunodetection method. Detector antibodies in buffer bind to MxA antigens in the sample, forming antigen-antibody complexes, and migrate onto a nitrocellulose matrix to be captured by immobilized antibodies on the test strip. More MxA antigen in the sample forms more antigen-antibody complexes, leading to a stronger fluorescence signal that is processed by the analyzer to show MxA concentration in the sample.
| Feature | Benefit |
|---|---|
| Sandwich immunodetection | Reliable quantitative measurement principle |
| Fluorescence signal | Measurable concentration values |
| Test strip technology | Anti-MxA at test line; chicken IgY at control line |
FIA Analyzer – Advanced Technical Platform
The GHM MxA US is used with the FIA Analyzer (VIM01), a compact fluorescence immunoassay analyzer featuring auto calibration, barcode identification, and a large memory capacity.
| Feature | Benefit |
|---|---|
| Auto calibration | Reduces manual calibration steps |
| Barcode identification | 2D barcode scanning for test device identification |
| Code chip coding | Automatic parameter recognition |
| Memory capacity | 50,000 results storage |
| Connectivity | Direct LIS/HIS connection |
| Display | 3.5-inch LCD screen |
| Dimensions | 173 × 210 × 75.8 mm |
| Weight | 1.5 kg |
| Printer | Built-in printer |
| Multi-parameter detection | Analyzer can detect 30+ parameters |
Wide Storage Temperature – No Cold Chain Required
The test kit and analyzer are designed for convenient storage and transport, with a storage temperature range of 2 ~ 30°C, eliminating the need for cold chain logistics.
| Specification | Detail |
|---|---|
| Kit storage temperature | 2 ~ 30°C |
| Analyzer storage temperature | -10 ~ 40°C |
| Analyzer operation temperature | 5 ~ 40°C |
| Operating temperature (kit) | 18 ~ 25°C |
| Relative humidity | 20 – 90% |
Simple Operation – Professional Laboratory Testing
The test procedure involves three simple steps: mix the sample with buffer, add the mixed specimen, and insert the device into the analyzer.
| Step | Action |
|---|---|
| 1 | Mix the sample with buffer |
| 2 | Add the mixed specimen |
| 3 | Insert device into the analyzer |
Product Specifications
| Specification | Detail |
|---|---|
| Model / SKU | GHM MxA US |
| Product Type | Myxovirus Resistance Protein A Test Kit (FIA) |
| Specimen | Whole blood, Serum, Plasma |
| Test Time | 15 minutes |
| Measuring Range | 10 ~ 300 ng/mL |
| Operating Temperature | 18 ~ 25°C |
| Storage Temperature | 2 ~ 30°C |
| Analyzer Compatibility | FIA Analyzer (VIM01) |
| Analyzer Display | 3.5-inch LCD |
| Analyzer Dimensions | 173 × 210 × 75.8 mm |
| Analyzer Weight | 1.5 kg |
| Analyzer Memory | 50,000 results |
| Analyzer Connectivity | Direct LIS/HIS |
| Analyzer Test Time | 10 ± 5 seconds |
| Analyzer Operation Temperature | 5 ~ 40°C |
| Analyzer Storage Temperature | -10 ~ 40°C |
| Relative Humidity | 20 – 90% |
| Intended Use | In vitro diagnostic use; professional use only |
| Package Options | Kit format |
Why Clinical Laboratories Choose Global Healthcare Medical
| Consideration | GHM MxA US |
|---|---|
| Quantitative results | Measurable MxA concentration values |
| Fast turnaround | 15 minutes per test |
| Flexible specimen types | Whole blood, serum, or plasma |
| Viral infection biomarker | MxA is elevated in acute viral infections and generally not in bacterial infections |
| Early detection | MxA elevation detectable within 1–2 hours of interferon induction |
| Auto calibration | Reduces manual steps |
| Large memory | 50,000 results storage |
| LIS/HIS connectivity | Direct data integration |
| Convenient storage | 2 ~ 30°C, no cold chain required |
| Simple operation | Three-step test procedure |
| Multi-parameter platform | Analyzer supports 30+ parameters |
About Global Healthcare Medical
Global Healthcare Medical is dedicated to connecting clinical laboratories, hospitals, and healthcare distributors with high-quality in vitro diagnostic devices designed for reliable performance. The GHM MxA US is part of our fluorescence immunoassay product line, developed to support efficient viral infection assessment and antibiotic stewardship in professional settings.
Our focus is on dependable performance, clear documentation, and responsive support for clinical and laboratory environments.
